title: Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation.
abstract: The zinc-finger protein A20 has crucial physiological functions as a dual inhibitor of nuclear factor-κB (NF-κB) activation and apoptosis in tumor necrosis factor (TNF) receptor 1 signaling pathway. Although the molecular basis for the anti-NF-κB function of A20 has been well elucidated, the anti-apoptotic function of A20 is largely unknown. Here, we report a novel mechanism underlying the anti-apoptotic function of A20: A20 blocks TNF-induced apoptosis through suppression of c-jun N-terminal kinase (JNK) by targeting apoptosis signal-regulating kinase1 (ASK1). First, the ectopic expression of A20 drastically inhibits TNF-induced JNK activation and apoptosis in multiple cell types including those deficient of NF-κB activation. Unexpectedly, the blunting effect of A20 on TNF-induced JNK activation is not mediated by affecting the TNFR1 signaling complex formation. Instead, A20 interacts with ASK1, an important MAPKK kinase in the JNK signaling cascade. More importantly, overexpression of wild-type A20, but not of mutant A20 (ZnF4; C624A, C627A), promotes degradation of the ASK1 through the ubiquitin-proteasome system. Taken together, the results from this study reveal a novel anti-apoptotic mechanism of A20 in TNF signaling pathway: A20 binds to ASK1 and mediates ASK1 degradation, leading to suppression of JNK activation and eventually blockage of apoptosis.
authors.affiliation: Department of Pharmacology, Research Institute for Medical Science, Infection Signaling Network Research Center, Daejeon Regional Cancer Center, College of Medicine, Chungnam National University, Daejeon, Korea.
authors.forename: M
authors.initials: M
authors.lastname: Won
authors.forename: K A
authors.initials: KA
authors.lastname: Park
authors.forename: H S
authors.initials: HS
authors.lastname: Byun
authors.forename: K-C
authors.initials: KC
authors.lastname: Sohn
authors.forename: Y-R
authors.initials: YR
authors.lastname: Kim
authors.forename: J
authors.initials: J
authors.lastname: Jeon
authors.forename: J H
authors.initials: JH
authors.lastname: Hong
authors.forename: J
authors.initials: J
authors.lastname: Park
authors.forename: J H
authors.initials: JH
authors.lastname: Seok
authors.forename: J M
authors.initials: JM
authors.lastname: Kim
authors.forename: W-H
authors.initials: WH
authors.lastname: Yoon
authors.forename: I-S
authors.initials: IS
authors.lastname: Jang
authors.forename: H M
authors.initials: HM
authors.lastname: Shen
authors.forename: Z G
authors.initials: ZG
authors.lastname: Liu
authors.forename: G M
authors.initials: GM
authors.lastname: Hur
mesh_terms: D017209:Apoptosis; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism*; D048848:MAP Kinase Kinase Kinase 5 / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism; D009687:Nuclear Proteins / Q000378:metabolism*; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000378:metabolism; D015398:Signal Transduction; D047992:TNF Receptor-Associated Factor 2 / Q000378:metabolism; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D054875:Ubiquitination
chemical_list: D004268:DNA-Binding Proteins; D047908:Intracellular Signaling Peptides and Proteins; D016328:NF-kappa B; D009687:Nuclear Proteins; D047888:Receptors, Tumor Necrosis Factor, Type I; D047992:TNF Receptor-Associated Factor 2; D014409:Tumor Necrosis Factor-alpha; D048031:JNK Mitogen-Activated Protein Kinases; D048848:MAP Kinase Kinase Kinase 5; C076529:TNFAIP3 protein, human; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3
references.citation: Nature. 2001 Nov 15;414(6861):313-7
references.pmid: 11713531
references.citation: Mol Cell Biol. 2007 Dec;27(23):8152-63
references.pmid: 17724081
references.citation: Nat Cell Biol. 2004 Feb;6(2):146-53
references.pmid: 14743220
references.citation: Cell. 2004 Nov 12;119(4):529-42
references.pmid: 15537542
references.citation: J Exp Med. 2009 May 11;206(5):981-9
references.pmid: 19380639
references.citation: Mol Cell Biol. 2002 Sep;22(17):6034-45
references.pmid: 12167698
references.citation: Immunol Rev. 2009 Mar;228(1):225-40
references.pmid: 19290931
references.citation: Trends Biochem Sci. 2009 Mar;34(3):128-35
references.pmid: 19233657
references.citation: Science. 1997 Jan 3;275(5296):90-4
references.pmid: 8974401
references.citation: Nat Immunol. 2004 Oct;5(10):1052-60
references.pmid: 15334086
references.citation: J Biol Chem. 2009 Mar 27;284(13):8217-21
references.pmid: 19008218
references.citation: Blood. 2004 Oct 15;104(8):2376-84
references.pmid: 15251990
references.citation: Cell. 2003 Oct 3;115(1):61-70
references.pmid: 14532003
references.citation: EMBO J. 2003 Aug 1;22(15):3898-909
references.pmid: 12881424
references.citation: J Virol. 1998 Nov;72(11):8463-71
references.pmid: 9765382
references.citation: Eur J Immunol. 1998 Nov;28(11):3594-604
references.pmid: 9842902
references.citation: J Cell Physiol. 2006 Aug;208(2):307-18
references.pmid: 16646083
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6721-5
references.pmid: 8692885
references.citation: J Biol Chem. 2005 Nov 4;280(44):37033-40
references.pmid: 16129676
references.citation: Nature. 2004 Aug 5;430(7000):694-9
references.pmid: 15258597
references.citation: Circ Res. 2002 Jun 28;90(12):1259-66
references.pmid: 12089063
references.citation: Annu Rev Immunol. 2009;27:693-733
references.pmid: 19302050
references.citation: Oncogene. 2007 Jul 12;26(32):4656-67
references.pmid: 17297453
references.citation: J Biol Chem. 1995 May 26;270(21):12343-6
references.pmid: 7539000
references.citation: Nature. 2009 Jun 4;459(7247):712-6
references.pmid: 19412163
references.citation: J Biol Chem. 2007 Mar 16;282(11):7777-82
references.pmid: 17220297
references.citation: EMBO Rep. 2001 Mar;2(3):222-8
references.pmid: 11266364
references.citation: Nature. 2003 Aug 14;424(6950):741; discussion 742
references.pmid: 12917673
references.citation: Nature. 2001 Nov 15;414(6861):308-13
references.pmid: 11713530
references.citation: Cell. 2005 Mar 11;120(5):649-61
references.pmid: 15766528
references.citation: Mol Cell. 2006 Mar 3;21(5):701-10
references.pmid: 16507367
references.citation: Science. 2000 Sep 29;289(5488):2350-4
references.pmid: 11009421
references.citation: Anticancer Res. 1999 Jul-Aug;19(4B):2863-8
references.pmid: 10652565
references.citation: Immunity. 2004 Sep;21(3):415-28
references.pmid: 15357952
references.citation: Trends Immunol. 2009 Aug;30(8):383-91
references.pmid: 19643665
references.citation: Cell. 2000 Oct 13;103(2):239-52
references.pmid: 11057897
references.citation: BMC Cancer. 2008 Feb 04;8:41
references.pmid: 18248671
references.citation: Science. 2008 Aug 1;321(5889):648-9
references.pmid: 18669850
references.citation: Science. 2010 Feb 26;327(5969):1135-9
references.pmid: 20185725
references.citation: Mol Cell Biol. 2001 May;21(10):3604-8
references.pmid: 11313486
references.citation: J Biol Chem. 1992 Jun 25;267(18):12424-7
references.pmid: 1618749
references.citation: Cell. 2008 Feb 8;132(3):344-62
references.pmid: 18267068